Ataxia‐Telangiectasia Mutated Kinase: A Potential New Target for Suppressing Inflammation in Heart Failure?
Author(s) -
Kukreja Rakesh C.
Publication year - 2014
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.114.001591
Subject(s) - ataxia telangiectasia , dna repair , dna damage , medicine , cancer research , kinase , cell cycle , chek1 , dna pkcs , microbiology and biotechnology , cell cycle checkpoint , protein kinase a , biology , genetics , dna , cancer
Ataxia‐telangiectasia mutated (ATM) kinase, the mutation of which causes the autosomal recessive disease ataxia‐telangiectasia, plays an essential role in the maintenance of genome stability (reviewed in ref. [1][1]). ATM (a serine/threonine protein kinase) senses DNA double‐strand breaks and
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom